These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31846001)

  • 21. Vasodilator therapy: implications in acute myocardial infarction and congestive heart failure.
    Cohn JN
    Am Heart J; 1982 Apr; 103(4 Pt 2):773-8. PubMed ID: 7039285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CHARM of a paradox.
    O'Rourke MF
    J Am Coll Cardiol; 2010 Jan; 55(3):257. PubMed ID: 20117408
    [No Abstract]   [Full Text] [Related]  

  • 23. Of vasodilation in the treatment of congestive heart failure.
    Burch GE
    JAMA; 1978 Mar; 239(13):1317-8. PubMed ID: 633534
    [No Abstract]   [Full Text] [Related]  

  • 24. Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure.
    Verbrugge FH; Dupont M; Finucan M; Gabi A; Hawwa N; Mullens W; Taylor DO; Young JB; Starling RC; Tang WH
    Eur J Heart Fail; 2015 Sep; 17(9):956-63. PubMed ID: 26213182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pump failure in acute heart failure. Improvement in the prognosis with vasodilator therapy].
    Meinertz T; Gilfrich HJ; Kersting F; Kasper W
    Med Welt; 1981 Apr; 32(14):445-7. PubMed ID: 7219156
    [No Abstract]   [Full Text] [Related]  

  • 26. Vasodilators across the heart failure spectrum not all patients, and not all vasodilators, are created equal.
    Solomon SD
    J Am Coll Cardiol; 2012 Jan; 59(5):452-4. PubMed ID: 22281247
    [No Abstract]   [Full Text] [Related]  

  • 27. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levosimendan use in several scenarios of acute heart failure.
    Tavares M; Andrade AC; Mebazaa A
    Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the basic sciences in the practice of cardiology.
    Katz AM
    J Mol Cell Cardiol; 1987 Jan; 19(1):3-17. PubMed ID: 3560237
    [No Abstract]   [Full Text] [Related]  

  • 30. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future directions in vasodilator therapy for heart failure.
    Cohn JN
    Am Heart J; 1991 Mar; 121(3 Pt 1):969-74. PubMed ID: 2000775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agents with vasodilator properties in acute heart failure: how to design successful trials.
    Mebazaa A; Longrois D; Metra M; Mueller C; Richards AM; Roessig L; Seronde MF; Sato N; Stockbridge NL; Gattis Stough W; Alonso A; Cody RJ; Cook Bruns N; Gheorghiade M; Holzmeister J; Laribi S; Zannad F
    Eur J Heart Fail; 2015 Jul; 17(7):652-64. PubMed ID: 26040488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
    Cogan JJ; Humphreys MH; Carlson CJ; Benowitz NL; Rapaport E
    Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.
    Bank AJ; Shammas RA; Mullen K; Chuang PP
    J Card Fail; 1998 Sep; 4(3):193-201. PubMed ID: 9754590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of chronic congestive heart failure to improve their quality of life--clinical study of thermal vasodilation therapy].
    Tei C; Tanaka N
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1475-82. PubMed ID: 8537753
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vasodilation therapy in severe cardiac insufficiency. A review and therapeutic proposals without invasive hemodynamic monitoring].
    Sørensen JN; Godtfredsen J
    Ugeskr Laeger; 1981 Oct; 143(43):2792-6. PubMed ID: 7324227
    [No Abstract]   [Full Text] [Related]  

  • 37. [On some complications and the mechanism of their pathogenesis in controlled hypotension].
    AVTSYN AP; VIKHERT TM; VIKHERT AM; LUKOMSKII GI
    Vopr Neirokhir; 1962; 26():19-22. PubMed ID: 13965687
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.
    Oster JR; Materson BJ
    Arch Intern Med; 1992 Apr; 152(4):704-10. PubMed ID: 1558426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences and value of vasodilation in myocardial insufficiency].
    Just H
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():87-97. PubMed ID: 7187166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.